US 8202551
Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same
granted A61PA61P19/04
Quick answer
US patent 8202551 (Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P19/04